Ming Li serves as Alvotech’s Chief Strategy Officer, where his responsibilities include investor relations, communications and other key strategic initiatives. Ming has over 20 years of experience in the pharmaceutical/biotech industry, including a variety of roles in research and development, quality, operations, process improvement, finance and corporate development. Prior to Alvotech, Ming served as Executive Vice President of Corporate Development at Alvogen. Ming joined Alvogen in 2009 as one of its first employees and was instrumental in the company’s growth and development. Prior to joining Alvogen, Ming worked at Actavis, where he served in a leadership role focused on operations and process improvement.
Ming graduated North Carolina State University with a B.Sc. in Chemistry. He is also a Lean Six Sigma Black Belt.